miRNA-mRNA Correlation-Network Modules in Human Prostate Cancer and the Differences between Primary and Metastatic Tumor Subtypes

Recent studies have shown the contribution of miRNAs to cancer pathogenesis. Prostate cancer is the most commonly diagnosed cancer in men. Unlike other major types of cancer, no single gene has been identified as being mutated in the majority of prostate tumors. This implies that the expression profiling of genes, including the non-coding miRNAs, may substantially vary across individual cases of this cancer. The within-class variability makes it possible to reconstruct or infer disease-specific miRNA-mRNA correlation and regulatory modular networks using high-dimensional microarray data of prostate tumor samples. Furthermore, since miRNAs and tumor suppressor genes are usually tissue specific, miRNA-mRNA modules could potentially differ between primary prostate cancer (PPC) and metastatic prostate cancer (MPC). We herein performed an in silico analysis to explore the miRNA-mRNA correlation network modules in the two tumor subtypes. Our analysis identified 5 miRNA-mRNA module pairs (MPs) for PPC and MPC, respectively. Each MP includes one positive-connection (correlation) module and one negative-connection (correlation) module. The number of miRNAs or mRNAs (genes) in each module varies from 2 to 8 or from 6 to 622. The modules discovered for PPC are more informative than those for MPC in terms of the implicated biological insights. In particular, one negative-connection module in PPC fits well with the popularly recognized miRNA-mediated post-transcriptional regulation theory. That is, the 3′UTR sequences of the involved mRNAs (∼620) are enriched with the target site motifs of the 7 modular miRNAs, has-miR-106b, -191, -19b, -92a, -92b, -93, and -141. About 330 GO terms and KEGG pathways, including TGF-beta signaling pathway that maintains tissue homeostasis and plays a crucial role in the suppression of the proliferation of cancer cells, are over-represented (adj.p<0.05) in the modular gene list. These computationally identified modules provide remarkable biological evidence for the interference of miRNAs in the development of prostate cancers and warrant additional follow-up in independent laboratory studies.

[1]  Hugues Sicotte,et al.  Genome-Wide Transcriptional Profiling Reveals MicroRNA-Correlated Genes and Biological Processes in Human Lymphoblastoid Cell Lines , 2009, PloS one.

[2]  Min Zhu,et al.  Identifying functional miRNA-mRNA regulatory modules with correspondence latent dirichlet allocation , 2010, Bioinform..

[3]  Tu Bao Ho,et al.  Finding microRNA regulatory modules in human genome using rule induction , 2008, BMC Bioinformatics.

[4]  D. Botstein,et al.  Singular value decomposition for genome-wide expression data processing and modeling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[6]  J. Massagué,et al.  The logic of TGFβ signaling , 2006 .

[7]  Michael E. Wall,et al.  SVDMAN-singular value decomposition analysis of microarray data , 2001, Bioinform..

[8]  Neil O. Carragher,et al.  The role of focal-adhesion kinase in cancer — a new therapeutic opportunity , 2005, Nature Reviews Cancer.

[9]  Avner Friedman,et al.  MicroRNA regulation of a cancer network: Consequences of the feedback loops involving miR-17-92, E2F, and Myc , 2008, Proceedings of the National Academy of Sciences.

[10]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[11]  Y. van de Peer,et al.  Module Network Inference from a Cancer Gene Expression Data Set Identifies MicroRNA Regulated Modules , 2010, PloS one.

[12]  Dongxiao Zhu,et al.  miRNA-Mediated Relationships between Cis-SNP Genotypes and Transcript Intensities in Lymphocyte Cell Lines , 2012, PloS one.

[13]  Dong Wang,et al.  Human MicroRNA Oncogenes and Tumor Suppressors Show Significantly Different Biological Patterns: From Functions to Targets , 2010, PloS one.

[14]  M. Malumbres,et al.  Multiple E2F-Induced MicroRNAs Prevent Replicative Stress in Response to Mitogenic Signaling , 2010, Molecular and Cellular Biology.

[15]  Chang-Zheng Chen,et al.  MicroRNAs as oncogenes and tumor suppressors. , 2005, The New England journal of medicine.

[16]  Yu Liang,et al.  BMC Genomics , 2007 .

[17]  R. Spang,et al.  Predicting the clinical status of human breast cancer by using gene expression profiles , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Manjunatha Jagalur,et al.  Causal inference of regulator-target pairs by gene mapping of expression phenotypes , 2005, BMC Genomics.

[19]  Xinglai Ji,et al.  Distinguishing between cancer driver and passenger gene alteration candidates via cross-species comparison: a pilot study , 2010, BMC Cancer.

[20]  Hanns Hatt,et al.  Activation of an Olfactory Receptor Inhibits Proliferation of Prostate Cancer Cells* , 2009, The Journal of Biological Chemistry.

[21]  Kathleen Marchal,et al.  Module networks revisited: computational assessment and prioritization of model predictions , 2009, Bioinform..

[22]  Kathleen Marchal,et al.  Comparative analysis of module-based versus direct methods for reverse-engineering transcriptional regulatory networks , 2009, BMC Systems Biology.

[23]  C. Sander,et al.  Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.

[24]  Jin-Tang Dong.  Prevalent mutations in prostate cancer , 2006, Journal of cellular biochemistry.

[25]  R. Stephens,et al.  Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. , 2008, Cancer research.

[26]  Francesca Meloni,et al.  An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. , 2010, Blood.

[27]  Yuhai Zhao,et al.  HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling , 2009, Neuroreport.

[28]  Stijn van Dongen,et al.  miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..

[29]  Walter J. Lukiw,et al.  An NF-κB-sensitive Micro RNA-146a-mediated Inflammatory Circuit in Alzheimer Disease and in Stressed Human Brain Cells* , 2008, Journal of Biological Chemistry.

[30]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[31]  Zhenbao Yu,et al.  Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. , 2008, Carcinogenesis.

[32]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[33]  Kun Zhang,et al.  svdPPCS: an effective singular value decomposition-based method for conserved and divergent co-expression gene module identification , 2010, BMC Bioinformatics.

[34]  Xinxia Peng,et al.  Computational identification of hepatitis C virus associated microRNA-mRNA regulatory modules in human livers , 2009, BMC Genomics.

[35]  P. Meltzer.  Cancer genomics: Small RNAs with big impacts , 2005, Nature.

[36]  E. Wiemer,et al.  miRNAs and cancer , 2006, Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research.

[37]  Irwin H Gelman,et al.  Focal adhesion kinase controls prostate cancer progression via intrinsic kinase and scaffolding functions. , 2011, Anti-cancer agents in medicinal chemistry.

[38]  Ming Lu,et al.  TransmiR: a transcription factor–microRNA regulation database , 2009, Nucleic Acids Res..

[39]  J. Massagué,et al.  The logic of TGFbeta signaling. , 2006, FEBS letters.